Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 4
2004 5
2005 6
2006 8
2007 10
2008 11
2009 9
2010 14
2011 22
2012 16
2013 10
2014 10
2015 12
2016 14
2017 8
2018 11
2019 12
2020 17
2021 10
2022 11
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

207 results

Results by year

Filters applied: . Clear all
Page 1
Circulating glioma biomarkers.
Kros JM, Mustafa DM, Dekker LJ, Sillevis Smitt PA, Luider TM, Zheng PP. Kros JM, et al. Among authors: luider tm. Neuro Oncol. 2015 Mar;17(3):343-60. doi: 10.1093/neuonc/nou207. Epub 2014 Sep 24. Neuro Oncol. 2015. PMID: 25253418 Free PMC article. Review.
Collagen analysis with mass spectrometry.
van Huizen NA, Ijzermans JNM, Burgers PC, Luider TM. van Huizen NA, et al. Among authors: luider tm. Mass Spectrom Rev. 2020 Jul;39(4):309-335. doi: 10.1002/mas.21600. Epub 2019 Sep 9. Mass Spectrom Rev. 2020. PMID: 31498911 Review.
Molecular markers for cervical cancer screening.
Güzel C, van Sten-Van't Hoff J, de Kok IMCM, Govorukhina NI, Boychenko A, Luider TM, Bischoff R. Güzel C, et al. Among authors: luider tm. Expert Rev Proteomics. 2021 Aug;18(8):675-691. doi: 10.1080/14789450.2021.1980387. Epub 2021 Sep 29. Expert Rev Proteomics. 2021. PMID: 34551656 Review.
Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry.
Noori S, Wijnands C, Langerhorst P, Bonifay V, Stingl C, Touzeau C, Corre J, Perrot A, Moreau P, Caillon H, Luider TM, Dejoie T, Jacobs JFM, van Duijn MM. Noori S, et al. Among authors: luider tm. Blood Cancer J. 2023 Feb 24;13(1):30. doi: 10.1038/s41408-023-00803-z. Blood Cancer J. 2023. PMID: 36828828 Free PMC article. No abstract available.
Proteomics in primary brain tumors.
Zheng PP, Kros JM, Sillevis-Smitt PA, Luider TM. Zheng PP, et al. Among authors: luider tm. Front Biosci. 2003 Jan 1;8:d451-63. doi: 10.2741/1008. Front Biosci. 2003. PMID: 12456299 Review.
M-protein diagnostics in multiple myeloma patients using ultra-sensitive targeted mass spectrometry and an off-the-shelf calibrator.
Wijnands C, Langerhorst P, Noori S, Keizer-Garritsen J, Wessels HJCT, Gloerich J, Bonifay V, Caillon H, Luider TM, van Gool AJ, Dejoie T, VanDuijn MM, Jacobs JFM. Wijnands C, et al. Among authors: luider tm. Clin Chem Lab Med. 2023 Oct 12;62(3):540-550. doi: 10.1515/cclm-2023-0781. Print 2024 Feb 26. Clin Chem Lab Med. 2023. PMID: 37823394 Free PMC article.
Peptide profiling of cerebrospinal fluid by mass spectrometry.
Dekker LJ, Burgers PC, Kros JM, Smitt PA, Luider TM. Dekker LJ, et al. Among authors: luider tm. Expert Rev Proteomics. 2006 Jun;3(3):297-309. doi: 10.1586/14789450.3.3.297. Expert Rev Proteomics. 2006. PMID: 16771702 Review.
207 results